Primary Care Enhanced Services

The NHS Lincolnshire Integrated Care Board is intending to award a contract under the Provider Selection Regime regulations for Primary Care Enhanced Services. This process involves direct awarding without prior competition, and it follows the Health Care Services (Provider Selection Regime) Regulations 2023. The services encompass a variety of primary care provisions including phlebotomy, specialised drug monitoring, and DVT assessment, all within the UKF30 region.

The procurement is at the award stage, with a standstill period for any provider representations until 12th September 2025. The contract is expected to commence on 1st April 2025 and continue until 31st March 2026, with a total value of £48,587. This tender creates significant opportunities for businesses specialising in healthcare services, particularly those focused on primary care provisions.

With the procurement method being a direct award, existing providers with proven capabilities in delivering quality and collaborative solutions might find this particularly advantageous. Small and medium enterprises (SMEs) in the healthcare sector could leverage this opportunity to enhance their service offerings and expand their reach. The focus on social value and innovation as key criteria further underscores the emphasis on quality service provision, making it an excellent growth opportunity for capable healthcare service providers.